🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Why Chicken Soup For The Soul Entertainment Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket

Published 05/04/2023, 13:16
Updated 05/04/2023, 14:41
© Reuters.  Why Chicken Soup For The Soul Entertainment Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
IXIC
-
CSSE
-

Benzinga - Gainers

  • RiceBran Technologies (NASDAQ: RIBT) gained 43.1% to $1.33 in pre-market trading after gaining 3% on Tuesday.
  • Addex Therapeutics Ltd (NASDAQ: ADXN) jumped 35.4% to $1.25 in pre-market trading. Addex said it completed $5 million equity financing.
  • Millennium Group International Holdings Limited (NASDAQ: MGIH) shares climbed 25.8% to $4.04 in pre-market trading after dipping around 20% on Tuesday.
  • Ebang International Holdings Inc. (NASDAQ: EBON) gained 17.8% to $7.00 in pre-market trading after dropping 15% on Tuesday.
  • Chicken Soup for the Soul Entertainment, Inc. (NASDAQ: CSSE) gained 14.1% to $1.86 in pre-market trading. Chicken Soup For The Soul Entertainment’s Form4 filing showed CEO bought 1.8 million shares of common stock.
  • Virios Therapeutics, Inc. (NASDAQ: VIRI) climbed 12.2% to $0.3876 in pre-market trading after dropping 4% on Tuesday. The company recently posted a narrower-than-expected quarterly loss.
  • InflaRx N.V. (NASDAQ: IFRX) gained 10.8% to $4.18 in pre-market trading. InflaRx shares jumped 84% on Tuesday after the company announced it received FDA Emergency Use Authorization for Gohibic for the treatment of critically-ill COVID-19 patients.
  • Bird Global, Inc. (NYSE: BRDS) gained 9.3% to $0.2415 in pre-market trading after dropping around 15% on Tuesday. Bird Global recently announced the purchase of shares by management and directors.
  • Pyxis Oncology, Inc. (NASDAQ: PYXS) climbed 9.3% to $3.75 in pre-market trading after dropping more than 15% on Tuesday.
  • Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) surged 7.2% to $0.7451 in pre-market trading after dropping 9% on Tuesday.
Losers
  • Secoo Holding Limited (NASDAQ: SECO) fell 19.2% to $1.18 in pre-market trading after jumping 143% on Tuesday.
  • Nuvve Holding Corp. (NASDAQ: NVVE) fell 17.4% to $0.6490 in pre-market trading after gaining over 30% on Tuesday. Nuvve Holding recently posted better-than-expected quarterly sales.
  • First Wave BioPharma, Inc. (NASDAQ: FWBI) shares dropped 15.6% to $2.27 in pre-market trading after gaining 11% on Tuesday. First Wave BioPharma recently announced a $4.0 million private placement priced at-the-market under Nasdaq rules.
  • Sono Group N.V. (NASDAQ: SEV) shares fell 12.4% to $0.2980 in pre-market trading after dropping 6% on Tuesday.
  • Histogen Inc. (NASDAQ: HSTO) fell 11.7% to $1.06 in pre-market. Histogen reported exclusive intellectual property license agreement with Johns Hopkins University.
  • DLocal Limited (NASDAQ: DLO) fell 11.4% to $15.00 in pre-market trading after the company posted weaker-than-expected Q4 results.
  • The NFT Gaming Company, Inc. (NASDAQ: NFTG) fell 11.4% to $1.77 in pre-market trading. The NFT Gaming Company shares gained around 50% on Tuesday after the company provided a shareholder update on game launches, AI, Gaxos platform and other initiatives.
  • Bullfrog AI Holdings, Inc. (NASDAQ: BFRG) fell 10.7% to $5.36 in pre-market trading. Bullfrog AI shares jumped around 28% on Tuesday after the company announced a worldwide license agreement with Johns Hopkins University Applied Physics Laboratory for use of patented technology powering the company's bfLEAP platform..
  • Assure Holdings Corp. (NASDAQ: IONM) fell 9.7% to $3.34 in pre-market trading. Assure Hldgs, on Monday, posted a FY loss of $40.06 per share.
  • Oncternal Therapeutics, Inc. (NASDAQ: ONCT) shares fell 8.2% to $0.3125 in pre-market trading after dropping 57% on Tuesday. Oncternal Therapeutics said it will suspend Phase 3 and the Phase 1/2 studies of zilovertamab in combination with ibrutinib, citing the rapidly changing commercial landscape for Bruton's tyrosine kinase inhibitors (BTK inhibitors).
Now Read This: Top 4 Materials Stocks That Set To Fly In April

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.